NEVVI Medicare utilization intelligence

← back

WHITE, RICHARDM.D. NPI 1700840980 Clinician

Internal Medicine · MOUNTAIN HOME, AR

Specialty Internal Medicine — from billed Medicare claims
Trained UNIVERSITY OF ARKANSAS COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 40 years since medical school (class of 1986, self-reported to CMS)
Location MOUNTAIN HOME, AR · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 87 codes billed · 172,875 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
MONUMENT HEALTH RAPID CITY HOSPITAL INC
2025–2026
HIGHLANDS ONCOLOGY GROUP PA
2023–2025
BAXTER COUNTY REGIONAL HOSPITAL INC
2019–2022

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2024-01

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Unlock to see the figure.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J9299 Injection, nivolumab, 1 mg
Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram
J0897 Injection, denosumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J9267 Injection, paclitaxel, 1 mg
J1453 Injection, fosaprepitant, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J1437 Injection, ferric derisomaltose, 10 mg
J2405 Injection, ondansetron hydrochloride, per 1 mg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
80053 Blood test, comprehensive group of blood chemicals
J2469 Injection, palonosetron hcl, 25 mcg
Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg
83615 Lactate dehydrogenase (enzyme) level
J3475 Injection, magnesium sulfate, per 500 mg
83735 Magnesium level
84100 Phosphate level
84550 Uric acid level, blood
82248 Bilirubin level, direct
96413 Administration of chemotherapy into vein, 1 hour or less
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J0640 Injection, leucovorin calcium, per 50 mg
J9045 Injection, carboplatin, 50 mg
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
J3480 Injection, potassium chloride, per 2 meq
96372 Injection of drug or substance under skin or into muscle
J9190 Injection, fluorouracil, 500 mg
J1200 Injection, diphenhydramine hcl, up to 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
J9060 Injection, cisplatin, powder or solution, 10 mg
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96417 Administration of additional new drug or substance into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
J3490 Unclassified drugs
82784 Gammaglobulin (immune system protein) measurement
96415 Administration of chemotherapy into vein, each additional hour
36415 Insertion of needle into vein for collection of blood sample
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96375 Injection of additional new drug or substance into vein
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
96360 Infusion into a vein for hydration, 31-60 minutes
82378 Carcinoembryonic antigen (cea) protein level
71270 Ct scan of chest before and after contrast
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
84153 Psa (prostate specific antigen) measurement, total
74178 Ct scan of abdomen and pelvis before and after contrast
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
96374 Injection of drug or substance into vein
82977 Glutamyltransferase (liver enzyme) level
96361 Infusion into a vein for hydration, each additional hour
96411 Administration of additional new drug or substance into vein using push technique
96523 Irrigation of implanted venous access drug delivery device
96416 Administration of prolonged chemotherapy into vein
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
84443 Blood test, thyroid stimulating hormone (tsh)
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
J1940 Injection, furosemide, up to 20 mg
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
82607 Cyanocobalamin (vitamin b-12) level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
82746 Folic acid level, serum
84436 Thyroxine (thyroid chemical), total
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
82306 Vitamin d-3 level
80400 Hormonal panel for adrenal gland assessment (adrenal gland insufficiency)
93306 Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
36591 Collection of blood sample from implanted device
71046 X-ray of chest, 2 views
71250 Ct scan of chest without contrast
90480 Admn sarscov2 vacc 1 dose
90471 Administration of vaccine
90653 Influenza vaccine, inactivated
G0008 Administration of influenza virus vaccine

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.